These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 20462842)

  • 21. Improved outcomes in the management of esophageal cancer with the addition of surgical resection to chemoradiation therapy.
    McKenzie S; Mailey B; Artinyan A; Metchikian M; Shibata S; Kernstine K; Kim J
    Ann Surg Oncol; 2011 Feb; 18(2):551-8. PubMed ID: 20839062
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Primary Malignant Melanoma of the Gastroesophageal Junction Treated With Immunotherapy: A Case Report.
    Attlassy N; Agbeh A; Patnaik R; Miller J; McCarthy J
    WMJ; 2023 Mar; 122(1):77-80. PubMed ID: 36940130
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Primary malignant melanoma of the esophagus treated by endoscopic ablation and interferon therapy.
    Herman J; Duda M; Lovecek M; Svach I
    Dis Esophagus; 2001; 14(3-4):239-40. PubMed ID: 11869328
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nodal metastasis from locally advanced esophageal cancer: how neoadjuvant therapy modifies their frequency and distribution.
    Castoro C; Scarpa M; Cagol M; Ruol A; Cavallin F; Alfieri R; Zanchettin G; Rugge M; Ancona E
    Ann Surg Oncol; 2011 Dec; 18(13):3743-54. PubMed ID: 21556952
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Local injection of interferon beta in malignant melanoma of the esophagus as adjuvant of systemic pre- and postoperative DAV chemotherapy: case report with 7 years of long-term survival.
    Kawada K; Kawano T; Nagai K; Nishikage T; Nakajima Y; Tokairin Y; Ogiya K; Tanaka K; Iwai T
    Gastrointest Endosc; 2007 Aug; 66(2):408-10. PubMed ID: 17643724
    [No Abstract]   [Full Text] [Related]  

  • 26. Adjuvant chemotherapy after esophagectomy: is there a role in the treatment of the lymph node positive thoracic esophageal squamous cell carcinoma?
    Lyu X; Huang J; Mao Y; Liu Y; Feng Q; Shao K; Gao S; Jiang Y; Wang J; He J
    J Surg Oncol; 2014 Dec; 110(7):864-8. PubMed ID: 24976079
    [TBL] [Abstract][Full Text] [Related]  

  • 27. REG1A expression status suggests chemosensitivity among advanced thoracic esophageal squamous cell carcinoma patients treated with esophagectomy followed by adjuvant chemotherapy.
    Sato Y; Motoyama S; Nanjo H; Ito S; Yoshino K; Sasaki T; Kuribayashi K; Nagaki Y; Imai K; Saito H; Minamiya Y; Ogawa J
    Ann Surg Oncol; 2013 Sep; 20(9):3044-51. PubMed ID: 23645481
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Radical esophagectomy for stage II and III thoracic esophageal squamous cell carcinoma followed by adjuvant radiotherapy with or without chemotherapy: Which is more beneficial?
    Zou B; Tu Y; Liao D; Xu Y; Wang J; Huang M; Ren L; Zhu J; Gong Y; Liu Y; Zhou L; Zhou X; Peng F; Lu Y
    Thorac Cancer; 2020 Mar; 11(3):631-639. PubMed ID: 31943824
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Triple-modality therapy for a woman with locally advanced thoracic esophageal adenocarcinoma, Part 2.
    Schefter TE; Patel M; McCarter M; Kane M; Russ PD; Nash SR; Shah RJ; Mitchell JD
    Oncology (Williston Park); 2005 Jun; 19(7):830, 835-6, 838 passim. PubMed ID: 16053033
    [No Abstract]   [Full Text] [Related]  

  • 30. Dacarbazine (DTIC)-based chemotherapy or chemoimmunotherapy of patients with disseminated malignant melanoma.
    Mulder NH; van der Graaf WT; Willemse PH; Koops HS; de Vries EG; Sleijfer DT
    Br J Cancer; 1994 Oct; 70(4):681-3. PubMed ID: 7522510
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chemoimmunotherapy with dacarbazine, cisplatin, interferon-alpha2b and interleukin-2 versus two cycles of dacarbazine followed by chemoimmunotherapy in patients with metastatic melanoma: a randomised phase II study of the European Organization for Research and Treatment of Cancer Melanoma Group.
    Punt CJ; Suciu S; Gore MA; Koller J; Kruit WH; Thomas J; Patel P; Lienard D; Eggermont AM; Keilholz U
    Eur J Cancer; 2006 Nov; 42(17):2991-5. PubMed ID: 17023156
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Melanoma metastases occuring 40 years after primary melanoma.
    Gerlini G; Tripo L; Sestini S; Brandani P; Giannotti V; Gattai R; Borgognoni L
    Acta Oncol; 2018 Oct; 57(10):1418-1420. PubMed ID: 29923761
    [No Abstract]   [Full Text] [Related]  

  • 33. Neoadjuvant chemoradiation versus chemotherapy for patients undergoing esophagectomy for esophageal cancer.
    Luu TD; Gaur P; Force SD; Staley CA; Mansour KA; Miller JI; Miller DL
    Ann Thorac Surg; 2008 Apr; 85(4):1217-23; discussion 1223-4. PubMed ID: 18355499
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The usefulness of neo- and adjuvant therapy in the treatment of cutaneous melanoma].
    Dzhabarov FR; Rozenko LIa; Pozdniakova VV; Nepomniashchaia EM
    Vopr Onkol; 2011; 57(4):521-4. PubMed ID: 22191247
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Utility of PET, CT, and EUS to identify pathologic responders in esophageal cancer.
    Swisher SG; Maish M; Erasmus JJ; Correa AM; Ajani JA; Bresalier R; Komaki R; Macapinlac H; Munden RF; Putnam JB; Rice D; Smythe WR; Vaporciyan AA; Walsh GL; Wu TT; Roth JA
    Ann Thorac Surg; 2004 Oct; 78(4):1152-60; discussion 1152-60. PubMed ID: 15464463
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Primary malignant melanoma of the esophagus].
    Kato N; Kamino K; Yamashita T; Umeyama K; Mitsuhashi T
    Gan No Rinsho; 1986 Sep; 32(11):1459-65. PubMed ID: 3773274
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Malignant rhino- and otobasal mucosal melanomas--therapy and outcome].
    Arndt S; Echternach M; Aschendorff A; Schipper J; Maier W
    Laryngorhinootologie; 2008 Jun; 87(6):412-6. PubMed ID: 18506652
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [A case of superficial primary malignant melanoma of the esophagus].
    Kato T; Harano M; Ono S; Sato D; Choda Y; Kanazawa T; Matsukawa H; Ojima Y; Hamada M; Shiozaki S; Okajima M; Ninomiya M
    Gan To Kagaku Ryoho; 2013 Nov; 40(12):2109-11. PubMed ID: 24394029
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preoperative therapy with concurrent paclitaxel/carboplatin/infusional 5-FU and radiation therapy in locoregional esophageal cancer: final results of a Minnie Pearl Cancer Research Network phase II trial.
    Meluch AA; Greco FA; Gray JR; Thomas M; Sutton VM; Davis JL; Kalman LA; Shaffer DW; Yost K; Rinaldi DA; Hainsworth JD
    Cancer J; 2003; 9(4):251-60. PubMed ID: 12967135
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term results of a phase II trial of neoadjuvant chemotherapy followed by esophagectomy for locally advanced esophageal neoplasm.
    Pennathur A; Luketich JD; Landreneau RJ; Ward J; Christie NA; Gibson MK; Schuchert M; Cooper K; Land SR; Belani CP
    Ann Thorac Surg; 2008 Jun; 85(6):1930-6; discussion 1936-7. PubMed ID: 18498797
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.